Healthpeak Properties to Announce Q1 Earnings on May 5
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 04 2026
0mins
Source: seekingalpha
- Earnings Announcement Schedule: Healthpeak Properties is set to release its Q1 2023 earnings on May 5 after market close, with consensus estimates predicting a FFO of $0.43 per share and revenue of $693.13 million, providing critical financial health indicators for investors.
- Market Expectation Analysis: If actual results meet expectations, it could bolster investor confidence in Healthpeak, particularly against the backdrop of its strategy to unlock senior housing value, potentially driving stock price appreciation.
- Dividend Declaration: Healthpeak Properties has declared a dividend of $0.1017 per share, demonstrating the company's commitment to returning value to shareholders while reflecting its stable cash flow and profitability, which may attract income-seeking investors.
- Industry Conference Participation: Healthpeak Properties is participating in the 2026 Citi Miami Global Property CEO Conference, indicating its active engagement and leadership within the industry, which could provide significant exposure for future strategic developments and market expansion.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DOC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DOC
Wall Street analysts forecast DOC stock price to fall
12 Analyst Rating
6 Buy
6 Hold
0 Sell
Moderate Buy
Current: 19.400
Low
16.71
Averages
19.23
High
21.00
Current: 19.400
Low
16.71
Averages
19.23
High
21.00
About DOC
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT). The Company acquires, develops, owns, leases, and manages healthcare real estate across the United States. It owns, operates, and develops real estate focused on healthcare discovery and delivery. The Company operates through three segments: outpatient medical, lab, and senior housing. Its outpatient medical and lab segments own, operates, and develops outpatient medical buildings, hospitals, and lab buildings. Its portfolio includes Baylor Scott & White Charles A. Sammons Cancer Center, 8 C1TY Blvd, The Boardwalk, Springwoods Outpatient Medical Facility: St Luke’s Health – Springwoods Village, Vantage, UF Health North Medical Building, Avondale Outpatient Medical Facility, Wesley Chapel Medical Building II: AdventHealth Wesley Chapel, Cambridge Discovery Park, and others. The Company owns approximately 700 properties nationwide.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Healthpeak Releases 2025 Corporate Impact Report
- Environmental Progress: Healthpeak achieved a 3.4% like-for-like reduction in energy use in 2025, totaling a 10.3% reduction since 2020, alongside a 0.5% reduction in greenhouse gas emissions, cumulatively down 26.9%, demonstrating the company's commitment to sustainability.
- Building Certifications: The company secured over 840,000 square feet of new LEED certifications, 14 new ENERGY STAR certifications, and 13 inaugural ENERGY STAR NextGen certifications, highlighting its significant achievements in building sustainability.
- Team Culture: Healthpeak continues to invest in employee development and community engagement, fostering a values-driven workplace culture guided by its WE CARE core values, which enhances employee satisfaction and loyalty.
- Governance Leadership: The company maintains strong corporate governance practices, including cybersecurity oversight and responsible AI usage, ensuring transparency and accountability to uphold stakeholder trust.
See More
Morgan Stanley Downgrades Life Sciences REITs Amid Market Uncertainty
- Rating Downgrade: Morgan Stanley downgraded Healthpeak Properties (DOC) from Overweight to Equal-weight, although the price target was raised from $20 to $22, indicating confidence in its strong senior housing, yet limited visibility on overall market recovery may hinder future growth.
- Market Pressure: Alexandria Real Estate Equities (ARE) was downgraded to Underweight, with analysts noting that despite some constructive leasing data, the Q1 performance still showed near-term pressure, reflecting uncertainty in market demand.
- Stock Price Reaction: During pre-market trading on Friday, DOC's stock fell 1.02% to $20.29, while ARE's stock decreased by 0.17% to $52.68, indicating market sensitivity to the rating changes.
- Future Outlook: Morgan Stanley stated that Healthpeak Properties' outlook would improve if lab market trends exceed the 3% to 4% estimates, while ARE needs tenant demand to convert into signed leases to stabilize occupancy and enhance same-store net operating income.
See More
Healthpeak Properties Dividend Outlook
- Dividend Volatility: Healthpeak Properties Inc's dividend amounts are influenced by the company's profitability fluctuations, and historical data indicates uncertainty regarding the sustainability of its dividends, prompting investors to assess future earnings cautiously.
- Annual Yield Expectations: While the current market anticipates a 6% annual yield for Healthpeak, actual returns may vary due to profitability instability, necessitating investor attention to the company's financial performance.
- Historical Data Reference: By analyzing Healthpeak's historical dividend chart, investors can better judge whether the recent dividend is likely to continue, enabling more informed investment decisions.
- Market Dynamics Impact: Fluctuations in market demand for dividend stocks may affect Healthpeak's dividend policy, and investors should monitor market trends and changes in the company's profitability to evaluate future dividend payment capabilities.
See More
Diversified Healthcare Shares Surge 5.9% Amid Positive Outlook
- Stock Price Surge: Diversified Healthcare (DHC) shares rose 5.9% in the last trading session to close at $8.79, with notable trading volume exceeding typical levels, reflecting increased investor optimism despite a 1.4% decline over the past four weeks.
- Financial Expectations: The upcoming quarterly report is expected to show FFO of $0.14 per share, representing a 75% year-over-year increase, while revenues are projected at $383.19 million, up 0.1% from the previous year, indicating the company's potential for growth in a stable operating environment.
- Estimate Revision Trends: While FFO and revenue growth expectations are crucial for assessing stock potential, empirical research indicates a strong correlation between trends in FFO estimate revisions and near-term stock price movements, making it essential for investors to monitor any changes in DHC's FFO estimates.
- Market Ranking: DHC currently holds a Zacks Rank of 3 (Hold), reflecting a cautious market sentiment regarding its future performance, prompting investors to closely watch its subsequent developments to determine if the stock can maintain its upward trajectory.
See More
Healthpeak Properties Q1 2026 Earnings Call Highlights
- Acquisition Opportunity: Healthpeak completed a once-in-a-decade acquisition at the Gateway campus in South San Francisco, signing 62,000 square feet of leases, which indicates strong leasing momentum and is expected to enhance future revenues and market positioning.
- IPO Proceeds: The company successfully completed the IPO of its senior housing business in March, with expected proceeds adding approximately $0.04 per share to earnings, thereby enhancing financial stability and investor confidence.
- Stock Buyback: Healthpeak repurchased $100 million of stock in April at a yield exceeding 10%, which not only boosted earnings per share expectations but also supported guidance for 2026 earnings.
- Financial Outlook: The company raised its 2026 adjusted FFO guidance to a range of $1.71 to $1.75 per share, reflecting strong operational performance and market demand, despite facing refinancing pressures and tenant exit risks.
See More
Significant Stock Price Movements for Multiple Companies
- Arm Holdings Surge: Ahead of its earnings report, Arm Holdings saw a nearly 13% jump on Nasdaq, with UBS analyst raising its 12-month price target from $175 to $245, indicating strong market optimism for its growth potential.
- Healthpeak Properties Strong Performance: The healthcare REIT soared 18% after first-quarter funds from operations and revenue exceeded Wall Street expectations, raising its second-quarter FFO guidance to $1.71 to $1.75, reflecting robust business momentum.
- CDW Stock Decline: CDW shares dropped 19% after reporting disappointing operating income in Q1, with adjusted EPS of $2.28 matching consensus, yet the company reaffirmed its 2026 outlook, raising concerns about future performance.
- Aurora Innovation Partnership: Aurora Innovation's stock rose 9% following a deal to provide driverless technology to Berkshire Hathaway's McLane, which is expected to enhance its competitive edge in the long-haul trucking market.
See More
Healthpeak Releases 2025 Corporate Impact Report
- Environmental Progress: Healthpeak achieved a 3.4% like-for-like reduction in energy use in 2025, totaling a 10.3% reduction since 2020, alongside a 0.5% reduction in greenhouse gas emissions, cumulatively down 26.9%, demonstrating the company's commitment to sustainability.
- Building Certifications: The company secured over 840,000 square feet of new LEED certifications, 14 new ENERGY STAR certifications, and 13 inaugural ENERGY STAR NextGen certifications, highlighting its significant achievements in building sustainability.
- Team Culture: Healthpeak continues to invest in employee development and community engagement, fostering a values-driven workplace culture guided by its WE CARE core values, which enhances employee satisfaction and loyalty.
- Governance Leadership: The company maintains strong corporate governance practices, including cybersecurity oversight and responsible AI usage, ensuring transparency and accountability to uphold stakeholder trust.
See More
Morgan Stanley Downgrades Life Sciences REITs Amid Market Uncertainty
- Rating Downgrade: Morgan Stanley downgraded Healthpeak Properties (DOC) from Overweight to Equal-weight, although the price target was raised from $20 to $22, indicating confidence in its strong senior housing, yet limited visibility on overall market recovery may hinder future growth.
- Market Pressure: Alexandria Real Estate Equities (ARE) was downgraded to Underweight, with analysts noting that despite some constructive leasing data, the Q1 performance still showed near-term pressure, reflecting uncertainty in market demand.
- Stock Price Reaction: During pre-market trading on Friday, DOC's stock fell 1.02% to $20.29, while ARE's stock decreased by 0.17% to $52.68, indicating market sensitivity to the rating changes.
- Future Outlook: Morgan Stanley stated that Healthpeak Properties' outlook would improve if lab market trends exceed the 3% to 4% estimates, while ARE needs tenant demand to convert into signed leases to stabilize occupancy and enhance same-store net operating income.
See More
Healthpeak Properties Dividend Outlook
- Dividend Volatility: Healthpeak Properties Inc's dividend amounts are influenced by the company's profitability fluctuations, and historical data indicates uncertainty regarding the sustainability of its dividends, prompting investors to assess future earnings cautiously.
- Annual Yield Expectations: While the current market anticipates a 6% annual yield for Healthpeak, actual returns may vary due to profitability instability, necessitating investor attention to the company's financial performance.
- Historical Data Reference: By analyzing Healthpeak's historical dividend chart, investors can better judge whether the recent dividend is likely to continue, enabling more informed investment decisions.
- Market Dynamics Impact: Fluctuations in market demand for dividend stocks may affect Healthpeak's dividend policy, and investors should monitor market trends and changes in the company's profitability to evaluate future dividend payment capabilities.
See More
Diversified Healthcare Shares Surge 5.9% Amid Positive Outlook
- Stock Price Surge: Diversified Healthcare (DHC) shares rose 5.9% in the last trading session to close at $8.79, with notable trading volume exceeding typical levels, reflecting increased investor optimism despite a 1.4% decline over the past four weeks.
- Financial Expectations: The upcoming quarterly report is expected to show FFO of $0.14 per share, representing a 75% year-over-year increase, while revenues are projected at $383.19 million, up 0.1% from the previous year, indicating the company's potential for growth in a stable operating environment.
- Estimate Revision Trends: While FFO and revenue growth expectations are crucial for assessing stock potential, empirical research indicates a strong correlation between trends in FFO estimate revisions and near-term stock price movements, making it essential for investors to monitor any changes in DHC's FFO estimates.
- Market Ranking: DHC currently holds a Zacks Rank of 3 (Hold), reflecting a cautious market sentiment regarding its future performance, prompting investors to closely watch its subsequent developments to determine if the stock can maintain its upward trajectory.
See More
Healthpeak Properties Q1 2026 Earnings Call Highlights
- Acquisition Opportunity: Healthpeak completed a once-in-a-decade acquisition at the Gateway campus in South San Francisco, signing 62,000 square feet of leases, which indicates strong leasing momentum and is expected to enhance future revenues and market positioning.
- IPO Proceeds: The company successfully completed the IPO of its senior housing business in March, with expected proceeds adding approximately $0.04 per share to earnings, thereby enhancing financial stability and investor confidence.
- Stock Buyback: Healthpeak repurchased $100 million of stock in April at a yield exceeding 10%, which not only boosted earnings per share expectations but also supported guidance for 2026 earnings.
- Financial Outlook: The company raised its 2026 adjusted FFO guidance to a range of $1.71 to $1.75 per share, reflecting strong operational performance and market demand, despite facing refinancing pressures and tenant exit risks.
See More
Significant Stock Price Movements for Multiple Companies
- Arm Holdings Surge: Ahead of its earnings report, Arm Holdings saw a nearly 13% jump on Nasdaq, with UBS analyst raising its 12-month price target from $175 to $245, indicating strong market optimism for its growth potential.
- Healthpeak Properties Strong Performance: The healthcare REIT soared 18% after first-quarter funds from operations and revenue exceeded Wall Street expectations, raising its second-quarter FFO guidance to $1.71 to $1.75, reflecting robust business momentum.
- CDW Stock Decline: CDW shares dropped 19% after reporting disappointing operating income in Q1, with adjusted EPS of $2.28 matching consensus, yet the company reaffirmed its 2026 outlook, raising concerns about future performance.
- Aurora Innovation Partnership: Aurora Innovation's stock rose 9% following a deal to provide driverless technology to Berkshire Hathaway's McLane, which is expected to enhance its competitive edge in the long-haul trucking market.
See More
